Trintellix Side Effects: Nausea Timeline
Reviewed byDaniel Montville, MD, Psychiatrist
Siggy Clinical Team · Last updated September 18, 2026
Key Takeaways
- Nausea is Trintellix's most common side effect and its most common reason for discontinuation, occurring in 15% to 20% of patients within the first one to two days of treatment.
- For most patients, nausea peaks in the first week and eases by around two weeks, though about 10% of patients on 10 to 20 mg still report some nausea at the end of six to eight weeks.
- Nausea is dose-related, so a lower starting dose or a temporary dose reduction can reduce severity without necessarily giving up on the medication.
- Trintellix's antidepressant effect builds gradually, with noticeable improvement often starting around week two and full effect typically not seen until week four or later.
- Sexual side effects occur less often with Trintellix than with many other antidepressants, but should still be reported since dose and switching strategies exist.
Nausea is the side effect most people associate with Trintellix, and for good reason: it is the most commonly reported adverse reaction and the most common reason patients stop taking it early. It is also, for most people, temporary and predictable enough to plan around.
What This Post Covers
- Why Nausea Is Trintellix’s Signature Side Effect
- The Nausea Timeline, Week by Week
- Why Nausea Is Dose-Related
- Trintellix Side Effect Timeline at a Glance
- Other Side Effects Worth Knowing About
- Why Side Effects Show Up Before the Benefit Does
- When to Call Your Prescriber
- How Siggy Tracks the Nausea Curve
- Bottom Line
Why Nausea Is Trintellix’s Signature Side Effect
Trintellix (vortioxetine) affects the serotonin system, and serotonin plays a major role in gastrointestinal function, not just mood. Roughly 90% to 95% of the body’s serotonin is found in the gut, so any medication that increases serotonin activity is likely to produce some gastrointestinal effect, and nausea is the one most consistently reported with Trintellix.
Per FDA-approved prescribing information for Trintellix, nausea is the most common adverse reaction reported in short-term placebo-controlled trials, and it was also the most common reason patients discontinued treatment because of an adverse reaction. Constipation and vomiting were the other two most frequently reported reactions in the same trials.
The Nausea Timeline, Week by Week
According to Trintellix’s FDA prescribing information, nausea most commonly occurred in the first week of treatment, with 15% to 20% of patients experiencing it within one to two days of starting the medication. It was usually considered mild or moderate in intensity, with a median duration of about two weeks, and occurred more often in women than men.
Nausea does not resolve for everyone on the same schedule, though. The same FDA prescribing information for Trintellix shows approximately 10% of patients taking Trintellix at 10 mg to 20 mg per day still had nausea at the end of six- to eight-week placebo-controlled studies. That means the typical pattern, peak in week one, mostly resolved by week two, does not apply to a meaningful minority of patients, which is exactly why ongoing tracking matters more than a single early check-in.
Why Nausea Is Dose-Related
According to a 2026 clinical review in Psychiatria Polska, nausea frequency with vortioxetine is dose-related, and even rapid dose escalation up to the maximum 20 mg dose did not appear to disproportionately worsen tolerability, an effect attributed to vortioxetine’s specific receptor-binding profile. In practical terms, this means a lower starting dose or a temporary reduction is a reasonable clinical tool for managing nausea, and it does not necessarily mean giving up on the medication altogether.
Trintellix Side Effect Timeline at a Glance
| Effect | Most Common Timing | Typical Pattern | What To Do |
|---|---|---|---|
| Nausea | Days 1 to 2, peaks week 1 | Resolves by week 2 for most, persists in about 10% | Take with food, consider dose adjustment |
| Constipation | Weeks 1 to 4 | Can persist longer than nausea | Hydration, fiber, report if severe |
| Vomiting | First 1 to 2 weeks | Usually follows severe nausea | Report if frequent or dehydrating |
| Sexual dysfunction | Ongoing | Less common than with many antidepressants | Report actively, dose or switch options exist |
| Antidepressant effect | Starts around week 2, full by week 4+ | Builds gradually | Continue as directed |
Other Side Effects Worth Knowing About
Constipation and vomiting round out the top three most commonly reported reactions, and constipation in particular can persist longer than nausea does for some patients. Per FDA data on Trintellix and sexual side effects, sexual side effects were voluntarily reported by a small percentage of patients across doses in short-term trials, with rates increasing modestly at higher doses, a lower rate than is typically reported with many other antidepressants, though still worth raising with a prescriber if it occurs.
Why Side Effects Show Up Before the Benefit Does
Per FDA-reviewed patient materials for Trintellix, the therapeutic effect of Trintellix was generally seen starting at week two, while the full antidepressant effect was generally not seen until week four or later, based on clinical trials using standardized depression rating scales. Nausea, by contrast, can appear within the first day or two. That gap, discomfort arriving well before benefit, is the single biggest reason people consider stopping Trintellix before it has had a chance to work, and it is worth planning for in advance rather than discovering it in week one.
When to Call Your Prescriber
Contact your prescriber promptly for new or worsening thoughts of self-harm, especially in the first months of treatment or after a dose change, signs of serotonin syndrome such as agitation, rapid heartbeat, or muscle rigidity, unusual bleeding or bruising, or eye pain and vision changes that could indicate an angle-closure glaucoma event. If you or someone you know is having thoughts of suicide, call or text 988 (Suicide and Crisis Lifeline) or call 911. Severe nausea that prevents eating or keeping fluids down for more than a day is also worth reporting rather than waiting out.
How Siggy Tracks the Nausea Curve
Because roughly one in ten patients still has nausea at the two-month mark while most others have fully resolved by week two, the useful clinical question is not just “do you have nausea,” it is “where are you on the curve compared to what’s expected.” That distinction is difficult to reconstruct from memory weeks after the fact.
Daily check-ins capture the actual trajectory as it happens, day by day, which gives your care team the information needed to decide whether to hold the current dose, adjust it, or try a different management strategy. Start your anonymous intake to see how ongoing tracking supports that kind of decision instead of relying on a single snapshot at your next visit.
Bottom Line
Trintellix’s nausea follows a predictable pattern for most patients: it shows up fast, often within the first day or two, peaks in the first week, and resolves within about two weeks as the body adjusts. It does not follow that pattern for everyone, and roughly one in ten patients on a therapeutic dose still has some nausea two months in. Taking the medication with food, starting at a lower dose, and tracking the trajectory rather than guessing at it are what make it possible to get through the early weeks and find out whether Trintellix works for you.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
How long does Trintellix nausea last?
Nausea most commonly occurs in the first week of treatment, with 15% to 20% of patients experiencing it within one to two days of starting. For most people it decreases over the following one to two weeks. About 10% of patients taking 10 to 20 mg per day still report some nausea at the end of six to eight weeks of treatment.
Why does Trintellix cause so much nausea?
Trintellix affects serotonin receptors throughout the body, including in the gut, where the majority of the body's serotonin is located. Increased serotonin activity in the gastrointestinal tract stimulates nausea, which is why nausea is common across many antidepressants that raise serotonin, not unique to Trintellix.
Is Trintellix nausea dose-related?
Yes. Clinical trial data show nausea frequency increases with dose, from 5 mg up through 20 mg per day. This is why a lower starting dose, a slower dose increase, or a temporary dose reduction are common strategies for managing nausea without discontinuing the medication.
How long does it take for Trintellix to start working?
Some improvement is often seen starting around week two, but the full antidepressant effect typically is not apparent until week four or later, based on standardized depression rating scales used in clinical trials. Side effects like nausea usually appear well before any therapeutic benefit is noticeable.
Does Trintellix cause sexual side effects?
Sexual side effects can occur but are reported less often with Trintellix than with many other antidepressants. In short-term studies, voluntarily reported sexual side effects occurred in a small percentage of patients, increasing modestly with dose. Report any sexual side effects to your prescriber, since management options exist.
What should I do if Trintellix nausea does not improve?
Taking the dose with food, taking it at bedtime so nausea is less noticeable during sleep, and starting at a lower dose are common first steps. If nausea is severe, prevents eating, or has not improved after several weeks, talk to your prescriber about a dose adjustment rather than stopping on your own.
Sources
- Takeda Pharmaceuticals America, Inc. Trintellix (vortioxetine) Prescribing Information. FDA, 2018.
- Wichniak A, Iwański M, Mitrić M. The use of vortioxetine in the treatment of depression following the failure of therapy with a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor. Psychiatria Polska. 2026;60(1):7-20.